Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis
LLYLilly(LLY) Seeking Alpha·2024-09-30 21:35

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up for a free trial to Growth Stock Forum.With all the focus on Eli Lilly's (NYSE: LLY ) obesity business, the rec ...